Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Emerging Therapies Drive Analytical Advancements

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Analyzing Exabytes

Effective analytics will eliminate failures, deviations, and non-conformances.

Emerging Therapies Drive Analytical Advancements

February 03, 2024

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Analyzing Exabytes

February 02, 2024

Effective analytics will eliminate failures, deviations, and non-conformances.

Addressing PK/PD Study Design Early in Development

February 02, 2024

Strategizing a PK/PD study approach in early phase development facilitates a successful clinical progression.

Lonza and Oxford Nanopore Partner on mRNA Analytics

February 02, 2024

Under a new collaboration, Lonza and Oxford Nanopore aim to commercialize a CGMP-validated test for advanced analysis of mRNA products.

Roche to Acquire Point-of-Care Technology from LumiraDx in $350 Million Deal

January 04, 2024

Roche will acquire select parts of the LumiraDx group related to that company’s point-of-care technology, which integrates multiple tests on a single instrument.

Proving It’s Clean with Analytics

January 02, 2024

Analytical methods and tools play a pivotal role in cleaning validation.

Tome brings $213 Million to the Programmable Genome Editing Party

December 28, 2023

Tome Bioscience is facilitating the transition in biology from the editing phase to the cut-and-paste phase.

AbbVie Collaborates with BigHat Biosciences on Next-Gen Therapeutic Antibodies

December 08, 2023

This collaboration will combine BigHat Biosciences’ AI/ML-guided Milliner platform with AbbVie's expertise in oncology and neuroscience to develop next-generation antibodies.

MilliporeSigma Launches AI Solution for Integrating Drug Discovery and Molecule Synthesis

December 08, 2023

MilliporeSigma’s new platform combines generative AI, machine learning, and computer-aided drug-design aimed at increasing the success rate of new drugs and therapies.

Using Image Analysis to Differentiate Particle Size and Shape in Drug Products with Multiple Components

December 06, 2023

Image analysis is crucial for particle analysis of complex finished drug products.